期刊文献+

自身免疫性疾病自身抗原的研究进展 被引量:1

Research progress of autoantigens in autoimmune diseases
下载PDF
导出
摘要 自身抗原是自身免疫性疾病(AD)发病进程中的重要因素,诱导针对自身抗原的免疫应答进而破坏自身组织是AD的主要特征。AD治疗一般以对症治疗及控制病情发展为主,可选临床药物存在一定限制。近年人们对自身抗原的研究不断深入,通过抗原特异性免疫疗法精准防治AD能够避免影响机体正常免疫应答,有望为AD诊断、治疗及预防提供新的思路。本文将结合近期研究进展,对AD的自身抗原及针对自身抗原的治疗方法进行概述。 Autoantigen is critical factor in pathogenesis of autoimmune diseases(AD).AD is characterized by induced immune response against autoantigens and destroyed tissues.Current treatments of AD are based on symptomatic treatment and disease development control with certain restrictions usually result in limited options on available clinical drugs.In recent years,more insightful researches on autoantigens are conducted and via antigen-specific immunotherapy,prevent and control AD accurately,as a result avoiding to destroy body’s normal immune response system are avaliable,which shed light on diagnosis,treatment and prevention of AD.This review will combine recent research progress to outline autoantigens of AD and treatment methods by targeting against autoantigens.
作者 罗秀娜 任军 贾凌云 姬芳玲(指导) LUO Xiuna;REN Jun;JIA Lingyun;JI Fangling(School of Bioengineering,Dalian University of Technology,Dalian 116024,China)
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2023年第1期172-177,共6页 Chinese Journal of Immunology
基金 国家自然科学青年基金(21506025) 中央高校基本科研业务费(DUT20YG107)资助。
关键词 自身免疫性疾病 自身抗原 特异性免疫治疗 Autoimmune diseases Autoantigens Specific immunotherapy
  • 相关文献

参考文献2

二级参考文献49

  • 1Choy E H, Panayi G S. Cytokine pathways and joint inflammation in rheumatoid arthritis[J]. N Engl J Med,2001 ;344(12) :907-916.
  • 2Panayi G S. B cells: a fundamental role in the pathogenesis of rheumatoid arthritis? [J]. Rheumatology (Oxford) ,2005;44 Suppl 2: ii3-ii7.
  • 3Edwards J C, Szczepanski L, Szechinski J et al. Efficacy of B-cell-targeted therapy with fituximab in patients with rheumatoid arthritis[J]. N Engl J Med, 2004 ; 350(25) :2572-2581.
  • 4Chesnut R W, Grey H M. Antigen presentation by B cells and its significance in T-B interactions[J]. Adv lmmunol, 1986;39:51-94.
  • 5Takemura S, Klimiuk P A, Braun Aet al. T cell activation in rheumatoid synovium is B cell dependent[ J] .J Immunol,2001 ; 167(8):4710-4718.
  • 6Genevay S, Hayem G, Verpillat P et al. An eight year prospective study of outcome prediction by antiperinuclear factor and antikeratin antibodies at onset of rheumatoid arthritis[ J]. Annals of the rheumatic diseases, 2002; 61 (8) :734-736.
  • 7Rudd P M, Elliott T, Cresswell Pet al. Glycosylation and the immune system[J]. Science, 2001 ;291 (5512) :2370-2376.
  • 8Firestein G S. Evolving concepts of rheumatoid arthritis[ J]. Nature, 2003; 423(6937) :356-361.
  • 9van Gaalen F, Ioan-Facsinay A, Huizinga T Wet al. The devil in the details: the emerging role of anticitrulline autoimmunity in rheumatoid arthritis[J] .J lmmunol,2005 ; 175(9) :5575-5580.
  • 10van Schaardenburg D, Hazes J M, de Boer A et al. Outcome of rheumatoid arthritis in relation to age and rheumatoid factor at diagnosis[ J]. J Rheumatology, 1993 ; 20( 1 ) : 45-52.

共引文献13

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部